A&D HOLON Holdings Company, Limited (TYO:7745)
Japan flag Japan · Delayed Price · Currency is JPY
2,916.00
0.00 (0.00%)
Aug 14, 2026, 3:30 PM JST

TYO:7745 Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
69,15369,32667,08361,95559,02851,736
Revenue Growth
2.11%3.34%8.28%4.96%14.09%6.84%
Gross Profit
31,38131,45130,20327,62026,30322,883
Operating Income
8,5009,2108,8137,9567,4765,497
Net Income
5,5605,9236,4685,2995,5243,573
Earnings Per Share
202.86216.13235.41192.73201.14172.66
EPS Growth
-19.79%-8.19%22.14%-4.18%16.50%6.91%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Semiconductor-Related Business - Japan
9,10011,11012,29510,3296,916-
Semiconductor-Related Business - Asia and Oceania
-15----
Measurement and Weighing Equipment Business - Americas
5,1365,0924,8184,8186,0013,965
Measurement and Weighing Equipment Business- Japan
24,00923,93920,93220,93219,84424,849
Measurement and Weighing Equipment Business - Asia and Oceania
9,4639,1327,4917,4918,1206,996
Measurement and Weighing Equipment Business - Europe
654618601601905869
Medical and Health Equipment Business- Americas
11,79011,13710,0069,7639,2897,628
Medical and Health Equipment Business - Japan
17,96317,04717,69316,48017,07815,224
Medical and Health Equipment Business - Asia and Oceania
9,0378,3928,6618,2119,0747,803
Medical and Health Equipment Business - Europe
11,03410,5988,8208,0329,3957,826
Unallocated Adjustment
-29,103-27,758-24,705-24,705-27,598-23,426
Total
69,14969,32266,61261,95259,02451,734

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
14,64113,75813,34614,64215,00311,882
Total Debt
11,76712,75013,57917,84221,82019,372
Net Cash (Debt)
2,8741,008-233-3,200-6,817-7,490
Net Cash Growth
------
Net Cash Per Share
104.8636.78-8.48-116.37-248.20-361.87

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-6,4696,5787,2014,0961,782
Capital Expenditures
--3,047-1,525-1,674-885-2,071
Free Cash Flow
-3,4225,0535,5273,211-289
Free Cash Flow Growth
--32.28%-8.58%72.13%--

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
45.38%45.37%45.02%44.58%44.56%44.23%
Operating Margin
12.29%13.29%13.14%12.84%12.67%10.63%
Pretax Margin
11.54%12.50%13.56%12.83%12.82%10.69%
Profit Margin
8.04%8.54%9.64%8.55%9.36%6.91%
FCF Margin
-4.94%7.53%8.92%5.44%-0.56%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
60.00055.00040.00035.00035.00025.000
Dividend Per Share Growth
33.33%37.50%14.29%0%40.00%0%
Dividend Yield
2.06%2.20%2.23%1.26%2.61%2.83%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
14.3711.567.7615.047.085.60
Forward PE
15.0211.337.2912.687.817.98
P/FCF Ratio
23.3420.029.9314.4212.17-
PS Ratio
1.150.990.751.290.660.39